Kubota Corp. KUBTY Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Kubota Corp. KUBTY Company Overview 

Stock Message Board http://investorshangout.com/search?q=KUBTY&am...mp;yt1=Go!

Kubota Corp. KUBTY Current Price and Quotes
Last Price 74.02
Previous Close 76.15 Open 74.38
Daily Range 74.38 - 73.90 52wk Range 88.38 - 49.40
Volume 10,600 Dividend 0.9461
Average Vol (3m) 58,216 Yield 1.2782
Kubota Corp. KUBTY
Company Information

2-47, Shikitsuhigashi
1-Chome, Naniwa-ku
Osaka 556-8601
Japan

Website: http://www.kubota.co.jp
Phone: +81-6-6648-2111

Kubota Corp. KUBTY
Kubota is the parent company of group engaged in the manufacturing and sale of engine equipment, industrial equipment and housing materials. Co.'s principal products include farm equipment, farm facilities, lawn mowers, engines for various equipment, construction equipment, ductile iron pipes, polyvinyl chloride pipes and fittings, valves, castings, water treatment equipment, incineration plants, industrial waste material disposal plants, waster material recycling plants, mini hydraulic turbine...



Kubota Corp. KUBTY
Financial Reportings and Disclosures

Reporting Status International Reporting: Tokyo Stock Exchange
Deregistered a/o Jul 16, 2013
Latest Report Mar 31, 2013 20-F
CIK 0000109821
Fiscal Year End 3/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 3320 - Iron & Steel Foundries
Incorporated In: Japan
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Daisuke Hatakake President
Kohichi Noda IR
Akio Takigawa IR Manager
Kouhei Shirosaka Finance & Controlling
Company Directors

Not Available
Company Notes

New York Office: 320 Park Ave., 23rd Floor, New York, NY 10022. Phone #: 212-355-2440
Formerly=Kubota, Ltd to 4-90
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Kubota Corp. KUBTY
KUBTY Security Details Other Company Securities

Share Structure

Market Value1 $18,592,594,942 a/o Sep 27, 2013
Shares Outstanding 1,255,916,978 a/o Mar 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record 49 a/o Sep 18, 2008
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) *  Sep 27, 2013
Dividend () Mar 26, 2002 Mar 28, 2002 Jul 05, 2002
Security Notes

Capital Change=4-76 shs increased by 10% stk div.
Latest Addt'l Issue=3-77 1,000,000 shs at $24.125 by Smith Barney Harris Upham & Co., Inc et al.
Ratio Change=1 ADR to 5 Com shs from 1 ADR to 20 Com shs. Basis: 4 for 1 forward split. Ex-date=7-15-02. Rec-date=7-5-02. Pay date=7-12-02.
Note = Delisted from NYSE MKT on 7-16-13
Capital Change=shs increased by 4 for 1 split. Ex-date=07/15/2002. Rec date=07/05/2002. Pay date=07/12/2002.
Non US Stock Exchange Listing

6326 - Tokyo Stock Exchange - Qualified
Short Selling Data

Short Interest 32,638 (-22.32%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

JPMorgan Depositary Receipts

Kubota Corp. KUBTY Recent News

Aug 20, 2013 OTC Daily Alert Stock Watch - Kubota Corp. (OTC: KUBTY)


Kubota Corp. KUBTY Financials
Period Ending Mar 31, 2013 Mar 31, 2012
Total Revenue 12,398,000 12,249,000
Cost of Revenue 9,006,000 8,941,000
Gross Profit 3,392,000 3,307,000
Operating Expenses

Research and Development - -
Sales, General and Admin. 2,191,000 2,023,000
Non-Recurring Items - -
Other - -
Operating Income 1,202,000 1,284,000
Income From Continuing Operations

Add'l Income/Expense Items 90,000 (34,000)
Earnings Before Interest and Tax 1,293,000 1,250,000
Interest Expense 14,000 23,000
Earnings Before Tax 1,279,000 1,227,000
Income Tax 433,000 444,000
Minority Interest 79,000 54,000
Equity Earnings Unconsolidated Subsidiary 15,000 20,000
Net Income Cont. Operations 782,000 748,000
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 782,000 748,000
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders 782,000 748,000

KUBTY Kubota Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=KUBTY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/KUBTY/quote
Stock Chart http://www.otcmarkets.com/stock/KUBTY/chart
Company Info http://www.otcmarkets.com/stock/KUBTY/company-info
Recent News http://www.otcmarkets.com/stock/KUBTY/news
Financials http://www.otcmarkets.com/stock/KUBTY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/KUBTY/filings
Short Sales http://www.otcmarkets.com/stock/KUBTY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/KUBTY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/KUBTY/research
Summary http://finance.yahoo.com/q?s=KUBTY
Historical Prices http://finance.yahoo.com/q/hp?s=KUBTY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=KUBTY
Basic Chart http://finance.yahoo.com/q/bc?s=KUBTY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=KUBTY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=KUBTY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=KUBTY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=KUBTY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=KUBTY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=KUBTY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=KUBTY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=KUBTY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=KUBTY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=KUBTY
Balance Sheet http://finance.yahoo.com/q/bs?s=KUBTY
Cash Flow http://finance.yahoo.com/q/cf?s=KUBTY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/KUBTY
Market Watch http://www.marketwatch.com/investing/stock/KUBTY
Bloomberg http://www.bloomberg.com/quote/KUBTY:US
Morningstar http://quotes.morningstar.com/stock/s?t=KUBTY
Bussinessweek http://investing.businessweek.com/research/st...cker=KUBTY
Barchart http://www.barchart.com/quotes/stocks/KUBTY
OTC Short Report http://otcshortreport.com/index.php?index=KUBTY
Investopedia http://www.investopedia.com/markets/stocks/KUBTY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading